LRMR Stock Analysis: Buy, Sell, or Hold?
LRMR - Larimar Therapeutics, Inc. Common Stock
$4.74
0.06 (1.28%)
▲
5d:
-2.27%
30d:
-13.03%
90d:
+24.41%
BUY
MODERATE Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: Apr 29, 2026
26d
Smart Money Accumulation
LRMR is down 5.7% this week, but smart money is accumulating calls. Top strike: $5 2026-05-15 with 2,918 OI. Call ratio: 85% View Scanner →
Strength: 6.3/10
Get Alerted When LRMR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: LRMR shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: LRMR shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: LRMR is currently trading at $4.74, which is considered fair relative to its 30-day fair value range of $4.17 to $5.47.
Technical Outlook: Technically, LRMR is in a strong uptrend. Immediate support is located at $4.21, while resistance sits at $4.92.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $16.70 (+256.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, LRMR is in a strong uptrend. Immediate support is located at $4.21, while resistance sits at $4.92.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $16.70 (+256.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$4.17 -
$5.47
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 256.8% below Wall St target ($16.70)
Fair Price Analysis
30-Day Fair Range
$4.17 -
$5.47
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$4.21
Resistance Level
$4.93
Current Trend
Strong Uptrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.60
Wall Street Target
$16.70
(+256.8%)
Share & Embed Analysis
Last updated: April 02, 2026 2:59 PM ET
Data refreshes hourly during market hours. Next update: 3:59 PM
Data refreshes hourly during market hours. Next update: 3:59 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LRMR showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
James E Flynn
BUY
5000000 shares
2026-02-27
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$873 | 58 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 59 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$94 | 56 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 46 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$101 | 61 BUY |
